Early post-operative acute phase response in patients with early graft dysfunction is predictive of 6-month and 12-month mortality in liver transplant recipients

Human Immunology

Volumn 77, Issue 10, 2016, Pages 952-960

  Oweira, Hani ^a,b   Lahdou, Imad ^a   Daniel, Volker ^a   Opelz, Gerhard ^a   Schmidt, Jan ^a,b   Zidan, Ahmed ^a,c   Mehrabi, Arianeb ^a   Sadeghi, Mahmoud ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Vascular and Visceral Surgery   (Switzerland)

^c ASSIUT UNIVERSITY   (Egypt)

Author keywords

CRP; Early graft dysfunction; Inflammatory responses; Transplantation

Indexed keywords

ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN; CD30 ANTIGEN; LIVER ENZYME; NEOPTERIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE;

ACUTE PHASE RESPONSE; ADULT; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL; BLOOD; DELAYED GRAFT FUNCTION; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; SURVIVAL ANALYSIS;

ACUTE-PHASE REACTION; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BILIRUBIN; C-REACTIVE PROTEIN; DELAYED GRAFT FUNCTION; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84990998511     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2016.07.234     Document Type: Review

References (44)

1. [1] Pareja, E., Cortes, M., Hervas, D., Mir, J., Valdivieso, A., Castell, J.V., et al. A score model for the continuous grading of early allograft dysfunction severity. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 21:1 (2015), 38–46.
2. [2] Olthoff, K.M., Kulik, L., Samstein, B., Kaminski, M., Abecassis, M., Emond, J., et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transplant.: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 16:8 (2010), 943–949.
3. [3] Berberat, P.O., Friess, H., Schmied, B., Kremer, M., Gragert, S., Flechtenmacher, C., et al. Differentially expressed genes in postperfusion biopsies predict early graft dysfunction after liver transplantation. Transplantation 82:5 (2006), 699–704.
4. [4] Friedman, B.H., Wolf, J.H., Wang, L., Putt, M.E., Shaked, A., Christie, J.D., et al. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transplant.: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18:2 (2012), 166–176.
5. [5] Kurian, S.M., Fouraschen, S.M., Langfelder, P., Horvath, S., Shaked, A., Salomon, D.R., et al. Genomic profiles and predictors of early allograft dysfunction after human liver transplantation. Am. J. Transplant.: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15:6 (2015), 1605–1614.
6. [6] Azarpira, N., Nikeghbalian, S., Kazemi, K., Geramizadeh, B., Malekpour, Z., Malek-Hosseini, S.A., Association of increased plasma interleukin-6 and TNF-alpha levels in donors with the complication rates in liver transplant recipients. Int. J. Organ Transplant. Med. 4:1 (2013), 9–14.
7. [7] Lautenschlager, I., Nashan, B., Schlitt, H.J., Ringe, B., Wonigeit, K., Pichlmayr, R., Early intragraft inflammatory events of liver allografts leading to chronic rejection. Transplant Int.: Official Journal of the European Society for Organ Transplantation 8:6 (1995), 446–451.
8. [8] Lautenschlager, I., Hockerstedt, K., Taskinen, E., Ahonen, J., Korsback, C., Salmela, K., et al. Fine-needle aspiration cytology of liver allografts in the pig. Transplantation 38:4 (1984), 330–334.
9. [9] Palombo, J.D., Burke, P.A., Moldawer, L.L., Forse, R.A., Lewis, W.D., Jenkins, R.L., Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation. J. Am. Coll. Surg. 179:2 (1994), 209–219.
10. [10] Asegaonkar, S.B., Asegaonkar, B.N., Takalkar, U.V., Advani, S., Thorat, A.P., C-reactive protein and breast cancer: new insights from old molecule. Int. J. Breast Cancer, 2015, 2015, 145647.
11. [11] Lelubre, C., Anselin, S., Zouaoui Boudjeltia, K., Biston, P., Piagnerelli, M., Interpretation of C-reactive protein concentrations in critically ill patients. BioMed Res. Int., 2013, 2013, 124021.
12. [12] Dinic-Radovic, V., Nagorni, A., Brzacki, V., Ristic, L., Radovic, M., Importance of certain pro-inflammatory indices in patients with liver cirrhosis and bacterial infection on prognosis and course of the disease. Med. Arh. 66:1 (2012), 19–23.
13. [13] Oweira, H., Lahdou, I., Daniel, V., Hofer, S., Mieth, M., Schmidt, J., et al. Early post-transplant neopterin associated with one year survival and bacteremia in liver transplant recipients. Hum. Immunol. 77:1 (2016), 115–120.
14. [14] Susal, C., Pelzl, S., Simon, T., Opelz, G., Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transpl. Proc. 36:1 (2004), 29–34.
15. [15] Barbieri, A., Dolcino, M., Tinazzi, E., Rigo, A., Argentino, G., Patuzzo, G., et al. Characterization of CD30/CD30L(+) cells in peripheral blood and synovial fluid of patients with rheumatoid arthritis. J. Immunol. Res., 2015, 2015, 729654.
16. [16] Iyer, A.S., Khaskhely, N.M., Leggat, D.J., Ohtola, J.A., Saul-McBeth, J.L., Khuder, S.A., et al. Inflammatory markers and immune response to pneumococcal vaccination in HIV-positive and -negative adults. PLoS ONE, 11(3), 2016, e0150261.
17. [17] Kemp, K., Kurtzhals, J.A., Akanmori, B.D., Adabayeri, V., Goka, B.Q., Behr, C., et al. Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol. 9:3 (2002), 720–722.
18. [18] Tinazzi, E., Barbieri, A., Rigo, A., Patuzzo, G., Beri, R., Gerli, R., et al. In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30(+)T cells. Immunol. Lett. 161:2 (2014), 236–240.
19. [19] Hirt-Minkowski, P., Roth, M., Honger, G., Amico, P., Hopfer, H., Schaub, S., Soluble CD30 correlates with clinical but not subclinical renal allograft rejection. Transplant Int.: Official Journal of the European Society for Organ Transplantation 26:1 (2013), 75–83.
20. [20] Zhou, T., Zhan, J., Hong, S., Hu, Z., Fang, W., Qin, T., et al. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci. Rep., 5, 2015, 10481.
21. [21] Ikegami, T., Shirabe, K., Yoshizumi, T., Aishima, S., Taketomi, Y.A., Soejima, Y., et al. Primary graft dysfunction after living donor liver transplantation is characterized by delayed functional hyperbilirubinemia. Am. J. Transplant.: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12:7 (2012), 1886–1897.
22. [22] Serracino-Inglott, F., Habib, N.A., Mathie, R.T., Hepatic ischemia-reperfusion injury. Am. J. Surg. 181:2 (2001), 160–166.
23. [23] Santiago, F., Bueno, P., Olmedo, C., Comino, A., Hassan, L., Ferron-Celma, I., et al. Time course of intraoperative cytokine levels in liver transplant recipients. Transpl. Proc. 38:8 (2006), 2492–2494.
24. [24] Jialal, I., Devaraj, S., The role of C-reactive protein activation of nuclear factor kappa-B in the pathogenesis of unstable angina. J. Am. Coll. Cardiol. 49:2 (2007), 195–197.
25. [25] Kanagasabapathy, G., Kuppusamy, U.R., Abd Malek, S.N., Abdulla, M.A., Chua, K.H., Sabaratnam, V., Glucan-rich polysaccharides from Pleurotus sajor-caju (Fr.) Singer prevents glucose intolerance, insulin resistance and inflammation in C57BL/6J mice fed a high-fat diet. BMC Complement. Alternat. Med., 12, 2012, 261.
26. [26] Enguix-Armada, A., Escobar-Conesa, R., La Torre, A.G., De La Torre-Prados, M.V., Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin. Chem. Lab. Med.: CCLM/FESCC, 2015.
27. [27] Shao, N., Cai, Q., High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer. Tumour Biol.: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 2015.
28. [28] Godnic, M., Stubjar, D., Skvarc, M., Jukic, T., Diagnostic and prognostic value of sCD14-ST-presepsin for patients admitted to hospital intensive care unit (ICU). Wien. Klin. Wochenschr., 2015.
29. [29] Shibutani, M., Maeda, K., Nagahara, H., Ohtani, H., Sugano, K., Ikeya, T., et al. Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer. Hepatogastroenterology 61:136 (2014), 2236–2240.
30. [30] Zheng, T.L., Cao, K., Liang, C., Zhang, K., Guo, H.Z., Li, D.P., et al. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis. Asian Pac. J. Cancer Prev.: APJCP 15:19 (2014), 8075–8081.
31. [31] Liu, Z.Q., Chu, L., Fang, J.M., Zhang, X., Zhao, H.X., Chen, Y.J., et al. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis. Asian J. Androl. 16:3 (2014), 467–471.
32. [32] Hu, Q., Gou, Y., Sun, C., Ding, W., Xu, K., Gu, B., et al. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Urol. Oncol. 32:1 (2014), 50.e1–50.e8.
33. [33] Zhang, W., He, J., Zhang, F., Huang, C., Wu, Y., Han, Y., et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J. Nephrol. 26:2 (2013), 243–253.
34. [34] Saito, K., Kihara, K., C-reactive protein as a biomarker for urological cancers. Nat. Rev. Urol. 8:12 (2011), 659–666.
35. [35] Tomizawa, M., Shinozaki, F., Hasegawa, R., Shirai, Y., Motoyoshi, Y., Sugiyama, T., et al. Elevated C-reactive protein level predicts lower gastrointestinal tract bleeding. Biomed. Rep. 4:6 (2016), 711–714.
36. [36] Koseoglu, Z., Ozkan, O.V., Semerci, E., Aslan, A., Yetim, I., Ucar, E., et al. The relationship between mortality and inflammation in patients with gastrointestinal bleeding. J. Int. Med. Res. 37:5 (2009), 1508–1514.
37. [37] Vidula, H., Tian, L., Liu, K., Criqui, M.H., Ferrucci, L., Pearce, W.H., et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann. Int. Med. 148:2 (2008), 85–93.
38. [38] Devran, O., Karakurt, Z., Adiguzel, N., Gungor, G., Mocin, O.Y., Balci, M.K., et al. C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit. Multidiscip. Respirat. Med., 7(1), 2012, 47.
39. [39] Herzig, K.A., Purdie, D.M., Chang, W., Brown, A.M., Hawley, C.M., Campbell, S.B., et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. J. Am. Soc. Nephrol.: JASN 12:4 (2001), 814–821.
40. [40] Moreau, R., Jalan, R., Arroyo, V., Acute-on-chronic liver failure: recent concepts. J. Clin. Exp. Hepatol. 5:1 (2015), 81–85.
41. [41] Preto-Zamperlini, M., Farhat, S.C., Perondi, M.B., Pestana, A.P., Cunha, P.S., Pugliese, R.P., et al. Elevated C-reactive protein and spontaneous bacterial peritonitis in children with chronic liver disease and ascites. J. Pediatr. Gastroenterol. Nutr. 58:1 (2014), 96–98.
42. [42] Fierbinteanu-Braticevici, C., Baicus, C., Tribus, L., Papacocea, R., Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). J. Gastrointest. Liver Dis.: JGLD 20:2 (2011), 153–159.
43. [43] Chung, H.S., Kim, E.S., Park, J.H., Park, C.S., Prediction of gross post-transplant outcomes based on the intra-operative decline in C-reactive protein in living donor liver transplantation. Transpl. Proc. 47:2 (2015), 431–437.
44. [44] Kapur, R., Heitink-Polle, K.M., Porcelijn, L., Bentlage, A.E., Bruin, M.C., Visser, R., et al. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. Blood 125:11 (2015), 1793–1802.